Abstract: . . .  Co-Chair; Paul S. Jellinger, MD, MACE, Co-Chair; Harold E. Lebovitz, MD, FACE, Chair of Writing Committee Medical Writer: Christopher G. Parkin, MS ACE/AACE Diabetes Recommendations Implementation Conference Page 2 2OAD-APTO!CHIEVE'LYCEMIC'OALS .AÕVETO4HERAPY 4YPE _ . . .
. . .  Paul S. Jellinger, MD, MACE, Co-Chair; Harold E. Lebovitz, MD, FACE, Chair of Writing Committee Medical Writer: Christopher G. Parkin, MS ACE/AACE Diabetes Recommendations Implementation Conference Page 2 2OAD-APTO!CHIEVE'LYCEMIC'OALS .AÕVETO4HERAPY 4YPE _ # . . .
. . .  Jellinger, MD, MACE, Co-Chair; Harold E. Lebovitz, MD, FACE, Chair of Writing Committee Medical Writer: Christopher G. Parkin, MS ACE/AACE Diabetes Recommendations Implementation Conference Page 2 2OAD-APTO!CHIEVE'LYCEMIC'OALS .AÕVETO4HERAPY 4YPE _ # %  . . .
. . .  Co-Chair; Harold E. Lebovitz, MD, FACE, Chair of Writing Committee Medical Writer: Christopher G. Parkin, MS ACE/AACE Diabetes Recommendations Implementation Conference Page 2 2OAD-APTO!CHIEVE'LYCEMIC'OALS .AÕVETO4HERAPY 4YPE _ # % %#  . . .
. . .  Harold E. Lebovitz, MD, FACE, Chair of Writing Committee Medical Writer: Christopher G. Parkin, MS ACE/AACE Diabetes Recommendations Implementation Conference Page 2 2OAD-APTO!CHIEVE'LYCEMIC'OALS .AÕVETO4HERAPY 4YPE _ # % %# ",-1&" . . .
--1721,5,172,2093,8603